Follow The Filings

NVAX position history

The shares of Novavax (NVAX) that Shah Capital Management reported in each quarter’s 13F.

Equity, COM NEW

Shares held by quarter

New Add Reduce Exit

  1. 2022 Q4: 715,000 shares, $7.4M, 1.7% of portfolio, New
  2. 2023 Q1: 4,251,076 shares, $29M, 8.6% of portfolio, Add +494.6%
  3. 2023 Q2: 15,212,588 shares, $111M, 10.5% of portfolio, Add +257.9%
  4. 2023 Q3: 6,330,756 shares, $46M, 10.8% of portfolio, Reduce −58.4%
  5. 2023 Q4: 7,780,756 shares, $37M, 9.6% of portfolio, Add +22.9%
  6. 2024 Q1: 8,117,827 shares, $39M, 10.9% of portfolio, Add +4.3%
  7. 2024 Q2: 9,662,090 shares, $122M, 26.5% of portfolio, Add +19.0%
  8. 2024 Q3: 9,815,541 shares, $124M, 24.2% of portfolio, Add +1.6%
  9. 2024 Q4: 11,148,846 shares, $90M, 18.1% of portfolio, Add +13.6%
  10. 2025 Q1: 11,131,846 shares, $71M, 14.6% of portfolio, Reduce −0.2%
  11. 2025 Q2: 11,511,780 shares, $73M, 14.1% of portfolio, Add +3.4%
  12. 2025 Q3: 11,811,780 shares, $102M, 18.3% of portfolio, Add +2.6%
  13. 2025 Q4: 14,558,780 shares, $98M, 18.9% of portfolio, Add +23.3%
  14. 2026 Q1: 14,845,097 shares, $121M, 23.2% of portfolio, Add +2.0%
  15. 2026 Q2: 14,165,577 shares, $133M, 25.4% of portfolio, Reduce −4.6%
  16. 2026 Q3: 12,173,481 shares, $132M, 21.7% of portfolio, Reduce −14.1%
Holdings date Value % of holdings Shares Filing date All 13F holders